Gary Gitnick

9.5k citations

113 papers · 7.4k indexed · 3 hit papers · h-index 35

Impact in

Hepatology top 0.1%
- Hepatitis C virus research
- Liver Diseases and Immunity
- Liver Disease and Transplantation
- Hepatitis Viruses Studies and Epidemiology
Epidemiology top 0.2%
- Hepatitis B Virus Studies
- Liver Disease Diagnosis and Treatment

Papers in ⓘ

Hepatology 55
- Hepatitis C virus research 34
- Liver physiology and pathology 11
- Hepatitis Viruses Studies and Epidemiology 9
Epidemiology 74
- Hepatitis B Virus Studies 45
- Liver Disease Diagnosis and Treatment 33

Co-authors: Cladd E. Stevens (3 shared papers)Lacy R. Overby (4 shared papers)Daniel W. Bradley (2 shared papers)R H Purcell (1 shared paper)Karin Berger (1 shared paper)Tatsuo Miyamura (1 shared paper)Ferruccio Bonino (1 shared paper)Harrison Alter (1 shared paper)
Journals: Gastroenterology (16 papers)Digestive Diseases and Sciences (6 papers)Hepatology (5 papers)American Journal of Kidney Diseases (5 papers)Scandinavian Journal of Gastroenterology (4 papers)
Partner nations: United States Italy Türkiye

In The Last Decade

Gary Gitnick

112 papers receiving 6.8k citations

Hit Papers

align trajectories log scale

Long-Term Mortality after Transfusion-Associated Non-A, Non-B Hepatitis 1992 · 570 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

1992 New England Journal of Medicine
1989 Science
1972 Gastroenterology

Peers

Countries citing papers authored by Gary Gitnick

Since Specialization

Citations

This map shows the geographic impact of Gary Gitnick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary Gitnick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary Gitnick more than expected).

Fields of papers citing papers by Gary Gitnick

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary Gitnick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary Gitnick. The network helps show where Gary Gitnick may publish in the future.

Co-authors

The 25 scholars most cited alongside Gary Gitnick, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Gary Gitnick Line = papers co-authored together Gary Gitnick links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 113 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	An Assay for Circulating Antibodies to a Major Etiologic Virus of Human Non-A, Non-B Hepatitis Science ·George Kuo, Q L Choo, Harrison Alter, Gary Gitnick, Allan G. Redeker, R H Purcell, Tatsuo Miyamura, Jules L. Dienstag, M J Alter, Cladd E. Stevens, Gary E. Tegtmeier, Ferruccio Bonino, Massimo Colombo, W.-S. Lee, C. Kuo, Karin Berger, Jeffrey R. Shuster, Lacy R. Overby, Daniel W. Bradley, Michael Houghton Hit paper breakdown →	1989	2733
2	Long-Term Mortality after Transfusion-Associated Non-A, Non-B Hepatitis New England Journal of Medicine ·Leonard B. Seeff, Zelma Buskell‐Bales, Elizabeth C. Wright, Stephen Durako, Harvey J. Alter, Frank L. Iber, F. Blaine Hollinger, Gary Gitnick, Robert G. Knodell, Robert P. Perrillo, Cladd E. Stevens, Charles G. Hollingsworth Hit paper breakdown →	1992	570
3	Clinical, Biochemical, and Histological Remission of Severe Chronic Active Liver Disease: A Controlled Study of Treatments and Early Prognosis Gastroenterology ·Roger D. Soloway, W.H.J. Summerskill, Archie H. Baggenstoss, Michael G. Geall, Gary Gitnick, Lila R. Elveback, Leslie J. Schoenfield Hit paper breakdown →	1972	542
4	Gastrointestinal and liver disease Medical Entomology and Zoology ·Gary Gitnick	1979	297
5	Mesalamine capsules for the treatment of active Crohn's disease: Results of a 16-week trial Gastroenterology ·John W. Singleton, Stephen B. Hanauer, Gary Gitnick, Mark A. Peppercorn, Malcolm Robinson, Lawrence D. Wruble, Edward L. Krawitt	1993	253
6	Extensive In Vivo Angiogenesis Following Controlled Release of Human Vascular Endothelial Cell Growth Factor: Implications for Tissue Engineering and Wound Healing Artificial Organs ·Yaşar Murat Elçin, Vivek Dixit, Gary Gitnick	2001	177
7	Hepatitis B Immune Globulin for Accidental Exposures among Medical Personnel: Final Report of a Multicenter Controlled Trial The Journal of Infectious Diseases ·(unknown), Virginia A. Lee, (unknown), Gary Gitnick, Khaled Fawaz, Girish N. Vyas, (unknown), John Senior, (unknown), (unknown), John Singleton, (unknown), Kemal Akdamar, (unknown), E. I. Winkelman, Gilbert M. Schiff, Theodore Hersh	1978	135
8	Restoration of liver function in gunn rats without immunosuppression using transplanted microencapsulated hepatocytes Hepatology ·Vivek Dixit, Ruth Darvasi, Marika Arthur, Maria Brezina, Klaus J. Lewin, Gary Gitnick	1990	119
9	Non-A, Non-B Posttransfusion Hepatitis—A Decade Later Gastroenterology ·Ronald L. Koretz, Olive Stone, Mariam Mousa, Gary Gitnick	1985	108
10	The long-term course of non-A, non-B post-transfusion hepatitis Gastroenterology ·Ronald L. Koretz, Olive Stone, Gary Gitnick	1980	103
11	Non-A, Non-B Hepatitis Transmission in Chimpanzees: A Project of the Transfusion-Transmitted Viruses Study Group Intervirology ·Blaine Hollinger, Gary Gitnick, Richard D. Aach, W. Szmuness, James W. Mosley, Cladd E. Stevens, Robert L. Peters, John M. Weiner, Jochewed Werch, Jerrold J. Lander	1978	94
12	Contrasting features and responses to treatment of severe chronic active liver disease with and without hepatitis BS antigen. Gut ·Solko W. Schalm, W.H.J. Summerskill, Gary Gitnick, Lila R. Elveback	1976	92
13	Viral Investigations in Ulcerative Colitis and Regional Enteritis Gastroenterology ·Gary W. Farmer, Monroe M. Vincent, David A. Fuccillo, Luiz Horta-Barbosa, Susan Ritman, John L. Sever, Gary Gitnick	1973	88
14	Clinical and Pathologic Findings of the Liver in the Acquired Immune Deficiency Syndrome (AIDS) American Journal of Clinical Pathology ·Ben J. Glasgow, Karl H. Anders, Lester J. Layfield, Kenneth D. Steinsapir, Gary Gitnick, Klaus J. Lewin	1985	77
15	Chronic active hepatitis Digestive Diseases and Sciences ·Ronald L. Koretz, Klaus J. Lewin, Jerry Higgins, N.D. Fagen, Gary Gitnick	1980	73
16	Preliminary report on isolation of mycobacteria from patients with Crohn's disease Digestive Diseases and Sciences ·Gary Gitnick, Judith Collins, Blaine L. Beaman, Dale L. Brooks, Marika Arthur, T Imaeda, Mary Palieschesky	1989	71
17	CRYOPRESERVED MICROENCAPSULATED HEPATOCYTES—TRANSPLANTATION STUDIES IN GUNN RATS Transplantation ·Vivek Dixit, Ruth Darvasi, Marika Arthur, Klaus J. Lewin, Gary Gitnick	1993	69
18	Post-Transfusion Chronic Liver Disease Gastroenterology ·Ronald L. Koretz, Stephen C. Suffin, Gary Gitnick, Karla Damus, Jude E. Mitchell	1976	68
19	Biological dynamics of viral load in hemodialysis patients with hepatitis C virus American Journal of Kidney Diseases ·Fabrizio Fabrizi, Paul Martin, Vivek Dixit, Maria Brezina, Mary J. Cole, S. Vinson, Mariam Mousa, Gary Gitnick	2000	62
20	Serum Alanine Aminotransferase in Hepatitis C Screening of Patients on Hemodialysis American Journal of Kidney Diseases ·Sammy Saab, Paul Martin, Maria Brezina, Gary Gitnick, Hal F. Yee	2001	61

About Gary Gitnick

Gary Gitnick is a scholar working on Hepatology, Epidemiology, Pharmacology, Infectious Diseases and Transplantation, having authored 113 papers that have together received 7.4k indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (45 papers), Hepatitis C virus research (34 papers), Liver Disease Diagnosis and Treatment (33 papers), Liver physiology and pathology (11 papers), Pancreatic function and diabetes (11 papers), Inflammatory Bowel Disease (11 papers), Drug-Induced Hepatotoxicity and Protection (9 papers) and Hepatitis Viruses Studies and Epidemiology (9 papers). The work is most often cited by research in Hepatology (5.1k citations), Epidemiology (5.1k citations), Transplantation (116 citations), Infectious Diseases (612 citations) and Gastroenterology (167 citations). Gary Gitnick has collaborated with scholars based in United States, Italy and Türkiye. Frequent co-authors include Cladd E. Stevens, Lacy R. Overby, Daniel W. Bradley, R H Purcell, Karin Berger, Tatsuo Miyamura, Ferruccio Bonino, Harrison Alter, M J Alter and Jules L. Dienstag. Their work appears in journals such as Gastroenterology, Digestive Diseases and Sciences, Hepatology, American Journal of Kidney Diseases and Scandinavian Journal of Gastroenterology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact